DIAGNOSTIC AND THERAPEUTIC STRATEGIES FOR CONDITIONS ASSOCIATED WITH THE FLJ13639 GENE

Provided are methods for determining a prognosis for an individual suspected of having or diagnosed with cancer, where a high CD24/low FLJ13639 ratio indicates an unfavorable prognosis. Also provided are methods for enhancing the activity of chemotherapeutic agents, and isolated, purified FLJ13639 p...

Full description

Saved in:
Bibliographic Details
Main Authors MEGUERDITCHIAN, ARI-NAREG, COIGNET, LIONEL J, NGANGA, ALAIN, JOHNSON, TIMOTHY
Format Patent
LanguageEnglish
French
German
Published 03.09.2008
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Provided are methods for determining a prognosis for an individual suspected of having or diagnosed with cancer, where a high CD24/low FLJ13639 ratio indicates an unfavorable prognosis. Also provided are methods for enhancing the activity of chemotherapeutic agents, and isolated, purified FLJ13639 proteins for use in improving the prognosis of an individual and for enhancing the activity of chemotherapeutic agents.
AbstractList Provided are methods for determining a prognosis for an individual suspected of having or diagnosed with cancer, where a high CD24/low FLJ13639 ratio indicates an unfavorable prognosis. Also provided are methods for enhancing the activity of chemotherapeutic agents, and isolated, purified FLJ13639 proteins for use in improving the prognosis of an individual and for enhancing the activity of chemotherapeutic agents.
Author MEGUERDITCHIAN, ARI-NAREG
JOHNSON, TIMOTHY
COIGNET, LIONEL J
NGANGA, ALAIN
Author_xml – fullname: MEGUERDITCHIAN, ARI-NAREG
– fullname: COIGNET, LIONEL J
– fullname: NGANGA, ALAIN
– fullname: JOHNSON, TIMOTHY
BookMark eNqNi00KwjAQRrPQhX93mAu4qKGFLkMySUYkKc2oy1IkrqQt1PujBQ_g6uPx3rcVq2Ec8kbcDCkXYmLSoIIB9tiqBq8LJ24VoyNMYGMLOgZDTDEkUClFTV9p4E7slxfYy7mQlazBYcC9WD_715wPv90JsMjaH_M0dnme-kce8rvDpqgrWcpSneQfyQdOoDG1
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate STRATEGIES DIAGNOSTIQUES ET THERAPEUTIQUES POUR DES PATHOLOGIES ASSOCIEES AU GENE FLJ13639
DIAGNOSTISCHE UND THERAPEUTISCHE STRATEGIEN FÜR MIT DEM GEN FLJ13639 ASSOZIIERTE LEIDEN
ExternalDocumentID EP1963535A2
GroupedDBID EVB
ID FETCH-epo_espacenet_EP1963535A23
IEDL.DBID EVB
IngestDate Fri Jul 19 15:17:28 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
German
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_EP1963535A23
Notes Application Number: EP20060848867
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20080903&DB=EPODOC&CC=EP&NR=1963535A2
ParticipantIDs epo_espacenet_EP1963535A2
PublicationCentury 2000
PublicationDate 20080903
PublicationDateYYYYMMDD 2008-09-03
PublicationDate_xml – month: 09
  year: 2008
  text: 20080903
  day: 03
PublicationDecade 2000
PublicationYear 2008
RelatedCompanies HEALTH RESEARCH, INC
RelatedCompanies_xml – name: HEALTH RESEARCH, INC
Score 2.7161336
Snippet Provided are methods for determining a prognosis for an individual suspected of having or diagnosed with cancer, where a high CD24/low FLJ13639 ratio indicates...
SourceID epo
SourceType Open Access Repository
SubjectTerms BEER
BIOCHEMISTRY
CHEMISTRY
DERIVATIVES THEREOF
ENZYMOLOGY
FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE
METALLURGY
MICROBIOLOGY
MUTATION OR GENETIC ENGINEERING
NUCLEIC ACIDS
NUCLEOSIDES
NUCLEOTIDES
ORGANIC CHEMISTRY
SPIRITS
SUGARS
VINEGAR
WINE
Title DIAGNOSTIC AND THERAPEUTIC STRATEGIES FOR CONDITIONS ASSOCIATED WITH THE FLJ13639 GENE
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20080903&DB=EPODOC&locale=&CC=EP&NR=1963535A2
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1NT4MwtFnUqDedGudXejDciBsFVg6LYW0ZLA7IZHO3BRCSXdjiMP59X5sxvejttS9t2pe-9r2-L4QeHZr2SGlTvZtmuW72U6KnhmPoxKHULpx3O1d5uieh7c_M8cJatNCqiYVReUK_VHJE4Kgc-L1W9_Xm5xOLK9_K7VO2gq71s5cMuNZox1R-O2h8OBBxxCOmMQaQFk4H8qBZxHLhtj4EKbovmUHMhzIoZfP7RfHO0FEMk1X1OWoVVRudsKbwWhsdT3b2bgB3rLe9QHMeuKMwek0Cht2Q48QXUzcWM9mWhY8TMQLJDoNSh1kU8kCFB2OVtTEAJMdvQeLLUdh7GfcIiAxYuq1dIuyJhPk6LHC5J8ZSxPutkCt0UK2r4hphi0h7Z8_MCqM0S5JSUDKpY-Z9gxRWtyQd1Plzmpt_cLfotHGQ6JI7dFB_fBb38ArX2YOi3zf_KYNa
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1dT4Mw8LKocb7p1Dg_-2B4I24UGDwshlEYzA3IZHNvCyAke2GLw_j3vTZj-qJv117atJdee9f7Ang0jaRLC92QO0mayWovoXKimIpMTcPQc_Ndz0Se7kmgezN1tNAWDVjVsTAiT-iXSI6IHJUhv1fivt78fGIx4Vu5fUpX2LV-duM-k2rt2ODfDhIb9J0oZKEt2TZCUjDt84OmUc3C2_oQJeweZwZnPuBBKZvfL4p7CkcRTlZWZ9DIyxY07brwWguOJzt7N4I71tuew5z51jAIX2PfJlbASOw5UytyZrzNCx_HzhAlO4JKHbHDgPkiPJiIrI0-Ihl582OPjyLueNSlKDIQ7rZ2AcR1YtuTcYHLPTGWTrTfCr2Eg3Jd5ldANMrtnV01zZVCLWhioJJpmGrWU2iudQrahvaf01z_g3uAphdPxsuxH7zcwEntLNGht3BQfXzmd_giV-m9oOU3VFCGTQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=DIAGNOSTIC+AND+THERAPEUTIC+STRATEGIES+FOR+CONDITIONS+ASSOCIATED+WITH+THE+FLJ13639+GENE&rft.inventor=MEGUERDITCHIAN%2C+ARI-NAREG&rft.inventor=COIGNET%2C+LIONEL+J&rft.inventor=NGANGA%2C+ALAIN&rft.inventor=JOHNSON%2C+TIMOTHY&rft.date=2008-09-03&rft.externalDBID=A2&rft.externalDocID=EP1963535A2